Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Supernus Pharm (SUPN)

Supernus Pharm (SUPN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,395,990
  • Shares Outstanding, K 53,019
  • Annual Sales, $ 520,400 K
  • Annual Income, $ 126,950 K
  • 60-Month Beta 1.25
  • Price/Sales 2.79
  • Price/Cash Flow 9.08
  • Price/Book 1.92
Trade SUPN with:

Options Overview

Details
  • Implied Volatility 57.27%
  • Historical Volatility 30.63%
  • IV Percentile 26%
  • IV Rank 29.20%
  • IV High 110.22% on 08/14/20
  • IV Low 35.43% on 06/08/21
  • Put/Call Vol Ratio 0.14
  • Today's Volume 16
  • Volume Avg (30-Day) 69
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 3,038
  • Open Int (30-Day) 3,133

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.17
  • Number of Estimates 3
  • High Estimate 0.22
  • Low Estimate 0.11
  • Prior Year 0.65
  • Growth Rate Est. (year over year) -73.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.17 +7.99%
on 07/30/21
30.35 -10.46%
on 07/06/21
-3.19 (-10.50%)
since 07/02/21
3-Month
25.17 +7.99%
on 07/30/21
34.29 -20.73%
on 06/16/21
-2.92 (-9.70%)
since 05/04/21
52-Week
17.20 +58.02%
on 10/29/20
34.29 -20.73%
on 06/16/21
+4.24 (+18.48%)
since 08/04/20

Most Recent Stories

More News
Supernus Pharmaceuticals (SUPN) Beats Q2 Earnings and Revenue Estimates

Supernus (SUPN) delivered earnings and revenue surprises of 152.94% and 4.82%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

SUPN : 27.18 (+1.08%)
Supernus: Q2 Earnings Snapshot

ROCKVILLE, Md. (AP) _ Supernus Pharmaceuticals Inc. (SUPN) on Wednesday reported second-quarter profit of $23.7 million.

SUPN : 27.18 (+1.08%)
Supernus Announces Second Quarter 2021 Financial Results

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today reported...

SUPN : 27.18 (+1.08%)
Supernus to Host Second Quarter 2021 Financial Results Conference Call

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced...

SUPN : 27.18 (+1.08%)
RSI Alert: Supernus Pharmaceuticals (SUPN) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

SUPN : 27.18 (+1.08%)
Is First Trust Small Cap Value AlphaDEX ETF (FYT) a Strong ETF Right Now?

Smart Beta ETF report for FYT

FYT : 49.26 (-2.05%)
SUPN : 27.18 (+1.08%)
GHC : 644.18 (-2.32%)
TGNA : 17.29 (-1.20%)
VBR : 168.68 (-1.52%)
IWN : 157.02 (-1.92%)
Thinking about buying stock in Fisker, Torchlight Energy, Intec Pharma, Supernus Pharmaceuticals, or Cyclo Therapeutics?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FSR, TRCH, NTEC, SUPN, and CYTH.

CYTH : 8.18 (-1.21%)
SUPN : 27.18 (+1.08%)
NTEC : 9.63 (-12.48%)
TRCH : 4.95 (+4.21%)
FSR : 14.77 (-0.20%)
Supernus to Present at Jefferies Virtual Healthcare Conference

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced...

SUPN : 27.18 (+1.08%)
Qelbree(TM) (viloxazine extended-release capsules), a New Non-Controlled Substance, Now Available for the Treatment of ADHD in Pediatric Patients 6-17 Years of Age

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced...

SUPN : 27.18 (+1.08%)
Should First Trust Small Cap Value AlphaDEX ETF (FYT) Be on Your Investing Radar?

Style Box ETF report for FYT

FYT : 49.26 (-2.05%)
SUPN : 27.18 (+1.08%)
GHC : 644.18 (-2.32%)
VBR : 168.68 (-1.52%)
TGNA : 17.29 (-1.20%)
IWN : 157.02 (-1.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit...

See More

Key Turning Points

3rd Resistance Point 28.15
2nd Resistance Point 27.69
1st Resistance Point 27.43
Last Price 27.18
1st Support Level 26.71
2nd Support Level 26.25
3rd Support Level 25.99

See More

52-Week High 34.29
Fibonacci 61.8% 27.76
Last Price 27.18
Fibonacci 50% 25.75
Fibonacci 38.2% 23.73
52-Week Low 17.20

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar